1. Home
  2. ONMD vs CLDI Comparison

ONMD vs CLDI Comparison

Compare ONMD & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONMD
  • CLDI
  • Stock Information
  • Founded
  • ONMD 2006
  • CLDI 2014
  • Country
  • ONMD United States
  • CLDI United States
  • Employees
  • ONMD N/A
  • CLDI N/A
  • Industry
  • ONMD
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ONMD
  • CLDI Health Care
  • Exchange
  • ONMD Nasdaq
  • CLDI Nasdaq
  • Market Cap
  • ONMD 16.5M
  • CLDI 14.0M
  • IPO Year
  • ONMD N/A
  • CLDI N/A
  • Fundamental
  • Price
  • ONMD $0.39
  • CLDI $0.48
  • Analyst Decision
  • ONMD
  • CLDI Strong Buy
  • Analyst Count
  • ONMD 0
  • CLDI 2
  • Target Price
  • ONMD N/A
  • CLDI $15.00
  • AVG Volume (30 Days)
  • ONMD 54.3K
  • CLDI 386.9K
  • Earning Date
  • ONMD 04-15-2025
  • CLDI 05-13-2025
  • Dividend Yield
  • ONMD N/A
  • CLDI N/A
  • EPS Growth
  • ONMD N/A
  • CLDI N/A
  • EPS
  • ONMD N/A
  • CLDI N/A
  • Revenue
  • ONMD $643,000.00
  • CLDI N/A
  • Revenue This Year
  • ONMD N/A
  • CLDI N/A
  • Revenue Next Year
  • ONMD N/A
  • CLDI N/A
  • P/E Ratio
  • ONMD N/A
  • CLDI N/A
  • Revenue Growth
  • ONMD N/A
  • CLDI N/A
  • 52 Week Low
  • ONMD $0.30
  • CLDI $0.35
  • 52 Week High
  • ONMD $3.37
  • CLDI $4.90
  • Technical
  • Relative Strength Index (RSI)
  • ONMD 30.42
  • CLDI 38.44
  • Support Level
  • ONMD $0.45
  • CLDI $0.41
  • Resistance Level
  • ONMD $0.55
  • CLDI $0.45
  • Average True Range (ATR)
  • ONMD 0.09
  • CLDI 0.07
  • MACD
  • ONMD 0.00
  • CLDI 0.02
  • Stochastic Oscillator
  • ONMD 34.29
  • CLDI 56.57

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

Share on Social Networks: